Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Report 2026(Status and Outlook)
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size was estimated at USD 1374.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Circulating Tumor Cells (CTC) Liquid Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Circulating Tumor Cells (CTC) Liquid Biopsy market.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
QIAGEN
Bio-Techne
Precision Medical
Aviva Systems Biological
Biocept
Fluxion Biosciences
Greiner Bio-One International GmbH
Ikonisys
Miltenyi Biotec
IVDiagnostics
BioFluidica
Canopus Medical
Biolidics
Creativ MicroTech
LungLife AI
Epic Sciences
Rarecells Diagnostics
ScreenCell
Menarini Silicon Biosystems
Market Segmentation (by Type)
Kits & Reagents
Blood Collection Tubes
Devices
Market Segmentation (by Application)
Research & Academic Institutes
Hospitals
Physician Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Circulating Tumor Cells (CTC) Liquid Biopsy Market
Overview of the regional outlook of the Circulating Tumor Cells (CTC) Liquid Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Circulating Tumor Cells (CTC) Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Circulating Tumor Cells (CTC) Liquid Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size was estimated at USD 1374.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Circulating Tumor Cells (CTC) Liquid Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Circulating Tumor Cells (CTC) Liquid Biopsy market.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
QIAGEN
Bio-Techne
Precision Medical
Aviva Systems Biological
Biocept
Fluxion Biosciences
Greiner Bio-One International GmbH
Ikonisys
Miltenyi Biotec
IVDiagnostics
BioFluidica
Canopus Medical
Biolidics
Creativ MicroTech
LungLife AI
Epic Sciences
Rarecells Diagnostics
ScreenCell
Menarini Silicon Biosystems
Market Segmentation (by Type)
Kits & Reagents
Blood Collection Tubes
Devices
Market Segmentation (by Application)
Research & Academic Institutes
Hospitals
Physician Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Circulating Tumor Cells (CTC) Liquid Biopsy Market
Overview of the regional outlook of the Circulating Tumor Cells (CTC) Liquid Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Circulating Tumor Cells (CTC) Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Circulating Tumor Cells (CTC) Liquid Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Circulating Tumor Cells (CTC) Liquid Biopsy
1.2 Key Market Segments
1.2.1 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
1.2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Product Life Cycle
3.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Circulating Tumor Cells (CTC) Liquid Biopsy Market Competitive Situation and Trends
3.8.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Circulating Tumor Cells (CTC) Liquid Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Circulating Tumor Cells (CTC) Liquid Biopsy Market
5.7 ESG Ratings of Leading Companies
6 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2020-2025)
6.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Price by Type (2020-2025)
7 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Sales by Application (2020-2025)
7.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
8 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SALES BY REGION
8.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region
8.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.2.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.3 North America
8.3.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.3.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.4.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.5.2 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.6.2 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.7.2 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Circulating Tumor Cells (CTC) Liquid Biopsy by Region(2020-2025)
9.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production
9.4.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production
9.5.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (2020-2025)
9.6.1 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Circulating Tumor Cells (CTC) Liquid Biopsy Production (2020-2025)
9.7.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.7.2 China Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 QIAGEN
10.1.1 QIAGEN Basic Information
10.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.1.4 QIAGEN Business Overview
10.1.5 QIAGEN SWOT Analysis
10.1.6 QIAGEN Recent Developments
10.2 Bio-Techne
10.2.1 Bio-Techne Basic Information
10.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.2.4 Bio-Techne Business Overview
10.2.5 Bio-Techne SWOT Analysis
10.2.6 Bio-Techne Recent Developments
10.3 Precision Medical
10.3.1 Precision Medical Basic Information
10.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.3.4 Precision Medical Business Overview
10.3.5 Precision Medical SWOT Analysis
10.3.6 Precision Medical Recent Developments
10.4 Aviva Systems Biological
10.4.1 Aviva Systems Biological Basic Information
10.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.4.4 Aviva Systems Biological Business Overview
10.4.5 Aviva Systems Biological Recent Developments
10.5 Biocept
10.5.1 Biocept Basic Information
10.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.5.4 Biocept Business Overview
10.5.5 Biocept Recent Developments
10.6 Fluxion Biosciences
10.6.1 Fluxion Biosciences Basic Information
10.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.6.4 Fluxion Biosciences Business Overview
10.6.5 Fluxion Biosciences Recent Developments
10.7 Greiner Bio-One International GmbH
10.7.1 Greiner Bio-One International GmbH Basic Information
10.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.7.4 Greiner Bio-One International GmbH Business Overview
10.7.5 Greiner Bio-One International GmbH Recent Developments
10.8 Ikonisys
10.8.1 Ikonisys Basic Information
10.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.8.4 Ikonisys Business Overview
10.8.5 Ikonisys Recent Developments
10.9 Miltenyi Biotec
10.9.1 Miltenyi Biotec Basic Information
10.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.9.4 Miltenyi Biotec Business Overview
10.9.5 Miltenyi Biotec Recent Developments
10.10 IVDiagnostics
10.10.1 IVDiagnostics Basic Information
10.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.10.4 IVDiagnostics Business Overview
10.10.5 IVDiagnostics Recent Developments
10.11 BioFluidica
10.11.1 BioFluidica Basic Information
10.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.11.4 BioFluidica Business Overview
10.11.5 BioFluidica Recent Developments
10.12 Canopus Medical
10.12.1 Canopus Medical Basic Information
10.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.12.4 Canopus Medical Business Overview
10.12.5 Canopus Medical Recent Developments
10.13 Biolidics
10.13.1 Biolidics Basic Information
10.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.13.4 Biolidics Business Overview
10.13.5 Biolidics Recent Developments
10.14 Creativ MicroTech
10.14.1 Creativ MicroTech Basic Information
10.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.14.4 Creativ MicroTech Business Overview
10.14.5 Creativ MicroTech Recent Developments
10.15 LungLife AI
10.15.1 LungLife AI Basic Information
10.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.15.4 LungLife AI Business Overview
10.15.5 LungLife AI Recent Developments
10.16 Epic Sciences
10.16.1 Epic Sciences Basic Information
10.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.16.4 Epic Sciences Business Overview
10.16.5 Epic Sciences Recent Developments
10.17 Rarecells Diagnostics
10.17.1 Rarecells Diagnostics Basic Information
10.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.17.4 Rarecells Diagnostics Business Overview
10.17.5 Rarecells Diagnostics Recent Developments
10.18 ScreenCell
10.18.1 ScreenCell Basic Information
10.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.18.4 ScreenCell Business Overview
10.18.5 ScreenCell Recent Developments
10.19 Menarini Silicon Biosystems
10.19.1 Menarini Silicon Biosystems Basic Information
10.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.19.4 Menarini Silicon Biosystems Business Overview
10.19.5 Menarini Silicon Biosystems Recent Developments
11 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST BY REGION
11.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast
11.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region
11.2.4 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Circulating Tumor Cells (CTC) Liquid Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2026-2035)
12.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2026-2035)
12.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Application (2026-2035)
12.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Circulating Tumor Cells (CTC) Liquid Biopsy
1.2 Key Market Segments
1.2.1 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
1.2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Product Life Cycle
3.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Circulating Tumor Cells (CTC) Liquid Biopsy Market Competitive Situation and Trends
3.8.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Circulating Tumor Cells (CTC) Liquid Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Circulating Tumor Cells (CTC) Liquid Biopsy Market
5.7 ESG Ratings of Leading Companies
6 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2020-2025)
6.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Price by Type (2020-2025)
7 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Sales by Application (2020-2025)
7.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
8 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SALES BY REGION
8.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region
8.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.2.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.3 North America
8.3.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.3.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.4.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.5.2 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country
8.6.2 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region
8.7.2 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Circulating Tumor Cells (CTC) Liquid Biopsy by Region(2020-2025)
9.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production
9.4.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production
9.5.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (2020-2025)
9.6.1 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Circulating Tumor Cells (CTC) Liquid Biopsy Production (2020-2025)
9.7.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Production Growth Rate (2020-2025)
9.7.2 China Circulating Tumor Cells (CTC) Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 QIAGEN
10.1.1 QIAGEN Basic Information
10.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.1.4 QIAGEN Business Overview
10.1.5 QIAGEN SWOT Analysis
10.1.6 QIAGEN Recent Developments
10.2 Bio-Techne
10.2.1 Bio-Techne Basic Information
10.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.2.4 Bio-Techne Business Overview
10.2.5 Bio-Techne SWOT Analysis
10.2.6 Bio-Techne Recent Developments
10.3 Precision Medical
10.3.1 Precision Medical Basic Information
10.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.3.4 Precision Medical Business Overview
10.3.5 Precision Medical SWOT Analysis
10.3.6 Precision Medical Recent Developments
10.4 Aviva Systems Biological
10.4.1 Aviva Systems Biological Basic Information
10.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.4.4 Aviva Systems Biological Business Overview
10.4.5 Aviva Systems Biological Recent Developments
10.5 Biocept
10.5.1 Biocept Basic Information
10.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.5.4 Biocept Business Overview
10.5.5 Biocept Recent Developments
10.6 Fluxion Biosciences
10.6.1 Fluxion Biosciences Basic Information
10.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.6.4 Fluxion Biosciences Business Overview
10.6.5 Fluxion Biosciences Recent Developments
10.7 Greiner Bio-One International GmbH
10.7.1 Greiner Bio-One International GmbH Basic Information
10.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.7.4 Greiner Bio-One International GmbH Business Overview
10.7.5 Greiner Bio-One International GmbH Recent Developments
10.8 Ikonisys
10.8.1 Ikonisys Basic Information
10.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.8.4 Ikonisys Business Overview
10.8.5 Ikonisys Recent Developments
10.9 Miltenyi Biotec
10.9.1 Miltenyi Biotec Basic Information
10.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.9.4 Miltenyi Biotec Business Overview
10.9.5 Miltenyi Biotec Recent Developments
10.10 IVDiagnostics
10.10.1 IVDiagnostics Basic Information
10.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.10.4 IVDiagnostics Business Overview
10.10.5 IVDiagnostics Recent Developments
10.11 BioFluidica
10.11.1 BioFluidica Basic Information
10.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.11.4 BioFluidica Business Overview
10.11.5 BioFluidica Recent Developments
10.12 Canopus Medical
10.12.1 Canopus Medical Basic Information
10.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.12.4 Canopus Medical Business Overview
10.12.5 Canopus Medical Recent Developments
10.13 Biolidics
10.13.1 Biolidics Basic Information
10.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.13.4 Biolidics Business Overview
10.13.5 Biolidics Recent Developments
10.14 Creativ MicroTech
10.14.1 Creativ MicroTech Basic Information
10.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.14.4 Creativ MicroTech Business Overview
10.14.5 Creativ MicroTech Recent Developments
10.15 LungLife AI
10.15.1 LungLife AI Basic Information
10.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.15.4 LungLife AI Business Overview
10.15.5 LungLife AI Recent Developments
10.16 Epic Sciences
10.16.1 Epic Sciences Basic Information
10.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.16.4 Epic Sciences Business Overview
10.16.5 Epic Sciences Recent Developments
10.17 Rarecells Diagnostics
10.17.1 Rarecells Diagnostics Basic Information
10.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.17.4 Rarecells Diagnostics Business Overview
10.17.5 Rarecells Diagnostics Recent Developments
10.18 ScreenCell
10.18.1 ScreenCell Basic Information
10.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.18.4 ScreenCell Business Overview
10.18.5 ScreenCell Recent Developments
10.19 Menarini Silicon Biosystems
10.19.1 Menarini Silicon Biosystems Basic Information
10.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
10.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Market Performance
10.19.4 Menarini Silicon Biosystems Business Overview
10.19.5 Menarini Silicon Biosystems Recent Developments
11 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST BY REGION
11.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast
11.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region
11.2.4 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Circulating Tumor Cells (CTC) Liquid Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2026-2035)
12.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2026-2035)
12.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Application (2026-2035)
12.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (M USD)
Table 4. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
Table 5. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison by Region (M USD)
Table 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy as of 2025)
Table 11. Global Market Circulating Tumor Cells (CTC) Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Circulating Tumor Cells (CTC) Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Circulating Tumor Cells (CTC) Liquid Biopsy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Type (K Units)
Table 27. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (M USD)
Table 28. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Type (2020-2025)
Table 29. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Type (2020-2025)
Table 30. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) by Type (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Type (2020-2025)
Table 32. Global Circulating Tumor Cells (CTC) Liquid Biopsy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Application
Table 34. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
Table 35. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Application (2020-2025) & (K Units)
Table 36. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application (2020-2025)
Table 37. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application (2020-2025)
Table 39. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Table 40. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 41. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region (2020-2025)
Table 42. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025)
Table 44. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 45. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 51. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) by Region(2020-2025)
Table 55. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2020-2025)
Table 57. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. QIAGEN Basic Information
Table 63. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 64. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. QIAGEN Business Overview
Table 66. QIAGEN SWOT Analysis
Table 67. QIAGEN Recent Developments
Table 68. Bio-Techne Basic Information
Table 69. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 70. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bio-Techne Business Overview
Table 72. Bio-Techne SWOT Analysis
Table 73. Bio-Techne Recent Developments
Table 74. Precision Medical Basic Information
Table 75. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 76. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Precision Medical Business Overview
Table 78. Precision Medical SWOT Analysis
Table 79. Precision Medical Recent Developments
Table 80. Aviva Systems Biological Basic Information
Table 81. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 82. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Aviva Systems Biological Business Overview
Table 84. Aviva Systems Biological Recent Developments
Table 85. Biocept Basic Information
Table 86. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 87. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biocept Business Overview
Table 89. Biocept Recent Developments
Table 90. Fluxion Biosciences Basic Information
Table 91. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 92. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Fluxion Biosciences Business Overview
Table 94. Fluxion Biosciences Recent Developments
Table 95. Greiner Bio-One International GmbH Basic Information
Table 96. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 97. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Greiner Bio-One International GmbH Business Overview
Table 99. Greiner Bio-One International GmbH Recent Developments
Table 100. Ikonisys Basic Information
Table 101. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 102. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Ikonisys Business Overview
Table 104. Ikonisys Recent Developments
Table 105. Miltenyi Biotec Basic Information
Table 106. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 107. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Miltenyi Biotec Business Overview
Table 109. Miltenyi Biotec Recent Developments
Table 110. IVDiagnostics Basic Information
Table 111. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 112. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. IVDiagnostics Business Overview
Table 114. IVDiagnostics Recent Developments
Table 115. BioFluidica Basic Information
Table 116. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 117. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. BioFluidica Business Overview
Table 119. BioFluidica Recent Developments
Table 120. Canopus Medical Basic Information
Table 121. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 122. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Canopus Medical Business Overview
Table 124. Canopus Medical Recent Developments
Table 125. Biolidics Basic Information
Table 126. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 127. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Biolidics Business Overview
Table 129. Biolidics Recent Developments
Table 130. Creativ MicroTech Basic Information
Table 131. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 132. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Creativ MicroTech Business Overview
Table 134. Creativ MicroTech Recent Developments
Table 135. LungLife AI Basic Information
Table 136. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 137. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. LungLife AI Business Overview
Table 139. LungLife AI Recent Developments
Table 140. Epic Sciences Basic Information
Table 141. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 142. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Epic Sciences Business Overview
Table 144. Epic Sciences Recent Developments
Table 145. Rarecells Diagnostics Basic Information
Table 146. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 147. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Rarecells Diagnostics Business Overview
Table 149. Rarecells Diagnostics Recent Developments
Table 150. ScreenCell Basic Information
Table 151. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 152. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. ScreenCell Business Overview
Table 154. ScreenCell Recent Developments
Table 155. Menarini Silicon Biosystems Basic Information
Table 156. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 157. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Menarini Silicon Biosystems Business Overview
Table 159. Menarini Silicon Biosystems Recent Developments
Table 160. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Circulating Tumor Cells (CTC) Liquid Biopsy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (M USD)
Table 4. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
Table 5. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison by Region (M USD)
Table 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy as of 2025)
Table 11. Global Market Circulating Tumor Cells (CTC) Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Circulating Tumor Cells (CTC) Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Circulating Tumor Cells (CTC) Liquid Biopsy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Type (K Units)
Table 27. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (M USD)
Table 28. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Type (2020-2025)
Table 29. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Type (2020-2025)
Table 30. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) by Type (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Type (2020-2025)
Table 32. Global Circulating Tumor Cells (CTC) Liquid Biopsy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) by Application
Table 34. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
Table 35. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Application (2020-2025) & (K Units)
Table 36. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application (2020-2025)
Table 37. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application (2020-2025)
Table 39. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Table 40. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 41. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region (2020-2025)
Table 42. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025)
Table 44. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 45. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 51. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) by Region(2020-2025)
Table 55. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2020-2025)
Table 57. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. QIAGEN Basic Information
Table 63. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 64. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. QIAGEN Business Overview
Table 66. QIAGEN SWOT Analysis
Table 67. QIAGEN Recent Developments
Table 68. Bio-Techne Basic Information
Table 69. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 70. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bio-Techne Business Overview
Table 72. Bio-Techne SWOT Analysis
Table 73. Bio-Techne Recent Developments
Table 74. Precision Medical Basic Information
Table 75. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 76. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Precision Medical Business Overview
Table 78. Precision Medical SWOT Analysis
Table 79. Precision Medical Recent Developments
Table 80. Aviva Systems Biological Basic Information
Table 81. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 82. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Aviva Systems Biological Business Overview
Table 84. Aviva Systems Biological Recent Developments
Table 85. Biocept Basic Information
Table 86. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 87. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biocept Business Overview
Table 89. Biocept Recent Developments
Table 90. Fluxion Biosciences Basic Information
Table 91. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 92. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Fluxion Biosciences Business Overview
Table 94. Fluxion Biosciences Recent Developments
Table 95. Greiner Bio-One International GmbH Basic Information
Table 96. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 97. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Greiner Bio-One International GmbH Business Overview
Table 99. Greiner Bio-One International GmbH Recent Developments
Table 100. Ikonisys Basic Information
Table 101. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 102. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Ikonisys Business Overview
Table 104. Ikonisys Recent Developments
Table 105. Miltenyi Biotec Basic Information
Table 106. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 107. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Miltenyi Biotec Business Overview
Table 109. Miltenyi Biotec Recent Developments
Table 110. IVDiagnostics Basic Information
Table 111. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 112. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. IVDiagnostics Business Overview
Table 114. IVDiagnostics Recent Developments
Table 115. BioFluidica Basic Information
Table 116. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 117. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. BioFluidica Business Overview
Table 119. BioFluidica Recent Developments
Table 120. Canopus Medical Basic Information
Table 121. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 122. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Canopus Medical Business Overview
Table 124. Canopus Medical Recent Developments
Table 125. Biolidics Basic Information
Table 126. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 127. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Biolidics Business Overview
Table 129. Biolidics Recent Developments
Table 130. Creativ MicroTech Basic Information
Table 131. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 132. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Creativ MicroTech Business Overview
Table 134. Creativ MicroTech Recent Developments
Table 135. LungLife AI Basic Information
Table 136. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 137. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. LungLife AI Business Overview
Table 139. LungLife AI Recent Developments
Table 140. Epic Sciences Basic Information
Table 141. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 142. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Epic Sciences Business Overview
Table 144. Epic Sciences Recent Developments
Table 145. Rarecells Diagnostics Basic Information
Table 146. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 147. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Rarecells Diagnostics Business Overview
Table 149. Rarecells Diagnostics Recent Developments
Table 150. ScreenCell Basic Information
Table 151. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 152. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. ScreenCell Business Overview
Table 154. ScreenCell Recent Developments
Table 155. Menarini Silicon Biosystems Basic Information
Table 156. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Overview
Table 157. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Menarini Silicon Biosystems Business Overview
Table 159. Menarini Silicon Biosystems Recent Developments
Table 160. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Circulating Tumor Cells (CTC) Liquid Biopsy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Circulating Tumor Cells (CTC) Liquid Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD), 2025-2035
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) (2020-2035)
Figure 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Product Life Cycle
Figure 13. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Share by Manufacturers in 2025
Figure 14. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Manufacturers in 2025
Figure 15. Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Circulating Tumor Cells (CTC) Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Circulating Tumor Cells (CTC) Liquid Biopsy Revenue in 2025
Figure 18. Industry Chain Map of Circulating Tumor Cells (CTC) Liquid Biopsy
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market PEST Analysis
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Type
Figure 27. Sales Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type in 2025
Figure 29. Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2020-2025)
Figure 30. Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application
Figure 33. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application in 2025
Figure 35. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application (2020-2025)
Figure 36. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application in 2025
Figure 37. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025)
Figure 40. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 43. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 45. U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 55. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region in 2024
Figure 68. China Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 80. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 82. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region in 2024
Figure 92. Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Type (2026-2035)
Figure 111. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Application (2026-2035)
Figure 112. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Circulating Tumor Cells (CTC) Liquid Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD), 2025-2035
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) (2020-2035)
Figure 6. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Product Life Cycle
Figure 13. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Share by Manufacturers in 2025
Figure 14. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Manufacturers in 2025
Figure 15. Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Circulating Tumor Cells (CTC) Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Circulating Tumor Cells (CTC) Liquid Biopsy Revenue in 2025
Figure 18. Industry Chain Map of Circulating Tumor Cells (CTC) Liquid Biopsy
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market PEST Analysis
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Type
Figure 27. Sales Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type in 2025
Figure 29. Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type (2020-2025)
Figure 30. Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application
Figure 33. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Application in 2025
Figure 35. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application (2020-2025)
Figure 36. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Application in 2025
Figure 37. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2020-2025)
Figure 40. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 43. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 45. U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 55. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region in 2024
Figure 68. China Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country in 2024
Figure 80. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country in 2024
Figure 82. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region in 2024
Figure 92. Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Circulating Tumor Cells (CTC) Liquid Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Circulating Tumor Cells (CTC) Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Type (2026-2035)
Figure 111. Global Circulating Tumor Cells (CTC) Liquid Biopsy Sales Forecast by Application (2026-2035)
Figure 112. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Application (2026-2035)
